News
The number of biopharma professionals let go has increased year over year for three straight months. In July, nearly 8,000 ...
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
MCLEAN, VA / ACCESS Newswire / July 31, 2025 / Gladstone Capital Corporation (Nasdaq:GLAD) announces the following event: ...
Apex Money Lending Group LLC has rolled out a new offer aimed at supporting entrepreneurs and investors in Colorado with ...
Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...
CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...
In a note to employees on Thursday, Moderna Inc. said it was laying off about 10% of its global workforce as part of the ...
4d
Pharmaceutical Technology on MSNModerna sharpens focus on $1.5bn cost cutting plan after 41% revenue slump"Moderna sharpens focus on $1.5bn cost cutting plan after 41% revenue slump" was originally created and published by ...
Discover key takeaways from Moderna's Q2 2025 earnings call, including FDA approvals, cost reductions, pipeline strategies, and financial updates.
Nevertheless, Moderna has lowered its revenue guidance for the year by $300 million. The company now expects to generate ...
The layoffs are part of an ongoing effort to reduce operating costs amid government and competitive challenges to its vaccine ...
Moderna topped Wall Street sales expectations and reported a lower-than-expected second-quarter loss on Friday, driven by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results